Key result
Amiodarone is increasingly recognized for pediatric resuscitation, though existing pediatric studies show limited efficacy and highlight the need for careful provider discretion.
Why the study?
Does amiodarone improve outcomes in pediatric patients requiring acute resuscitation?
Does amiodarone improve outcomes in pediatric patients requiring acute resuscitation?
While amiodarone is recommended in AHA guidelines for pediatric resuscitation, existing pediatric studies show limited efficacy, necessitating careful provider discretion.
Requires careful discretion in pediatric resuscitation; leaves open efficacy questions pending higher-level evidence.
Amiodarone has gained recognition as an antiarrhythmic medication after recent publication of the newly revised American Heart Association guidelines for pediatric resuscitation. Although support for the widespread use of amiodarone in adults has been supported by research, the few pediatric studies demonstrate limited efficacy and highlight the need for additional data. Because of the nature of the need for this type of resuscitation medication, controlled prospective studies will be difficult to obtain if not morally contraindicated. This article reviews the properties of amiodarone and the pertinent pediatric studies to provide healthcare providers supplemental information regarding amiodarone when choosing antiarrhythmics for acute resuscitation. Individual providers need to discern whether the pediatric data available supports widespread acceptance into current treatment regimens.
No takes yet. Share an insight, caveat, or question.
Michele R. McKee (2003) conducted a review in Pediatric resuscitation and arrhythmias. Amiodarone was evaluated. Amiodarone is increasingly recognized for pediatric resuscitation, though existing pediatric studies show limited efficacy and highlight the need for careful provider discretion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: